SCHEMBL30108023

SCHEMBL30108023

Nc1nc(-c2ccco2)cc(-n2nnc3cc(C(=O)O)ccc32)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.47
ALDH1A1 P00352 4/20 0.46
POLB P06746 4/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
GAA P10253 3/20 0.46
MAPT P10636 3/20 0.46
NSD2 O96028 1/20 0.46
THRB P10828 1/20 0.46
PABPC1 P11940 1/20 0.46
TNNI3 P19429 1/20 0.46
TNNT2 P45379 1/20 0.46
TNNC1 P63316 1/20 0.46
ADORA2A P29274 5/20 0.42
ADORA1 P30542 5/20 0.42
ADORA3 P0DMS8 2/20 0.42
ADORA2B P29275 2/20 0.42
HCAR3 P49019 6/20 0.42
KDM4E B2RXH2 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30107994 0.88 PTGS1 (0.50) PTGS1ALDH1A1POLBMEN1KMT2A
SCHEMBL30107959 0.85 KDM4E (0.44) ALDH1A1GAAADORA2AADORA1ADORA3
SCHEMBL30108019 0.83 KEAP1 (0.39) PTGS1ALDH1A1POLBL3MBTL1MEN1
SCHEMBL30108012 0.82 TSHR (0.58) PTGS1ALDH1A1POLBL3MBTL1GAA
SCHEMBL30108014 0.82 KDM4E (0.42) ALDH1A1GAAADORA2AADORA1ADORA3
SCHEMBL30108051 0.82 ALDH1A1 (0.47) ALDH1A1POLBL3MBTL1MEN1KMT2A
SCHEMBL30108028 0.81 KDM4E (0.43) PTGS1ALDH1A1L3MBTL1GAAADORA2A
SCHEMBL30107951 0.80 PTGS1 (0.46) PTGS1ALDH1A1POLBMEN1KMT2A
SCHEMBL30107978 0.79 KDM4E (0.44) ALDH1A1GAAADORA2AADORA1ADORA3
SCHEMBL30107980 0.78 ROCK1 (0.45) PTGS1ALDH1A1GAAADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed